Soluble RAGE is deficient in neutrophilic asthma and COPD

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 721-729

  Sukkar, M B ^a   Wood, L G ^b   Tooze, M ^b   Simpson, J L ^b   McDonald, V M ^b,c   Gibson, P G ^b,c   Wark, P A B ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Airway inflammation; Endogenous secretory receptor for advanced glycation endproducts; High mobility group box 1; Neutrophil; Serum amyloid A; Soluble receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG FLUID; LUNG FUNCTION; LUNG LAVAGE; LUNG RECEPTOR; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHILIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR POTENTIAL; RECEPTOR SENSITIVITY;

ADULT; AGED; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HIGH MOBILITY GROUP PROTEINS; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, IMMUNOLOGIC; REPRESSOR PROTEINS; SERUM AMYLOID A PROTEIN;

EID: 84860324666     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00022011     Document Type: Article

References (30)

1. Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Ann Rev Immunol 2010; 28: 367-388.
2. Zhang L, Bukulin M, Kojro E, et al. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 2008; 283: 35507-35516.
3. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010; 42: 36-44.
4. Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in COPD. Am J Respir Crit Care Med 2010; 181: 917-927.
5. Wu L, Ma L, Nicholson LFB, et al. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med 2011; 105: 329-336.
6. Watanabe T, Asai K, Fujimoto H, et al. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 2011; 105: 519-525.
7. Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J 2011; 37: 516-522.
8. Miniati M, Monti S, Basta G, et al. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res 2011; 12: 37.
9. Simpson JL, Phipps S, Gibson PG. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther 2009; 124: 86-95.
10. Frommhold D, Kamphues A, Hepper I, et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 2010; 116: 841-849.
11. Wang Y, Wang H, Piper MG, et al. sRAGE induces human monocyte survival and differentiation. J Immunol 2010; 185: 1822-1835.
12. Scott HA, Gibson PG, Garg ML, et al. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011; 38: 594-602.
13. McDonald VM, Simpson JL, Higgins I, et al. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing 2011; 40: 42-49.
14. McDonald VM, Higgins I, Simpson JL, et al. The importance of clinical management problems in older people with COPD and asthma: do patients and physicians agree? Prim Care Respir J 2011; [Epub ahead of print DOI: 10.4104/pcrj.2011.00025].
15. Verrills NM, Irwin JA, He XY, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183: 1633-1643.
16. Simpson JL, Grissell TV, Douwes J, et al. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62: 211-218. (Pubitemid 46579799)
17. Hudson BI, Carter AM, Harja E, et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J 2008; 22: 1572-1580. (Pubitemid 351656797)
18. Yamamoto Y, Miura J, Sakurai S, et al. Assaying soluble forms of receptor for advanced glycation end products. Aterioscler Thromb Vasc Biol 2007; 27: e33-e34. (Pubitemid 46809444)
19. Raucci A, Cugusi S, Antonelli A, et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008; 22: 3716-3727.
20. Vazzana N, Santilli F, Cuccurullo C, et al. Soluble forms of RAGE in internal medicine. Intern Emerg Med 2009; 4: 389-401.
21. Kumano-Kuramochi M, Ohnishi-Kameyama M, Xie Q, et al. Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability. Biochem Biophys Res Commun 2009; 386: 130-134.
22. Jang Y, Kim JY, Kang S-M, et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 2007; 56: 199-205. (Pubitemid 46074066)
23. Li K, Dai D, Zhao B, et al. Association between the RAGE G82S polymorphism and Alzheimer's disease. J Neural Transm 2010; 117: 97-104.
24. MakamM, Diaz D, Laval J, et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci USA 2009; 106: 5779-5783.
25. van Zoelen MAD, van der Sluijs KF, Achouiti A, et al. Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. Virology 2009; 391: 265-273.
26. van Zoelen MAD, Schouten M, de Vos AF, et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009; 182: 4349-4356.
27. El Kebir D, Jozsef L, Filep JG. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J Leukoc Biol 2008; 84: 600-606.
28. Shang G-H, Jia C-Q, Tian H, et al. Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer. Respir Med 2009; 103: 1949-1953.
29. Ozseker F, Buyukozturk S, Depboylu B, et al. Serum amyloid A in induced sputum of asthmatics: a new look to an old marker. Int Immunopharmacol 2006; 6: 1569-1576.
30. Bozinovski S, Hutchinson A, Thompson M, et al. Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 269-278.